Concepedia

Yanni Zhu

YZ

Statistics

Publications

35

Citations

4.8K

H-Index

24

Active since

2009

Affiliations

Gilead Sciences (United States)(Current)

Harvard University

Massachusetts General Hospital

University of California, Los Angeles

Emory University

Yanni Zhu is an author at Gilead Sciences (United States) specializing in medicine, viral hepatitis, and oncology.

Publications per year

2009–2024

35

Publications

35

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson et al. · New England Journal of Medicine · 2014 · 1.3K citations

, , +12

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

, , +17

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

, , +12

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Ira M. Jacobson, Eric Lawitz, Edward Gane et al. · Gastroenterology · 2017 · 239 citations · Full text

, , +12

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial

Naim Alkhouri, Robert Herring, Heidi Kabler et al. · Journal of Hepatology · 2022 · 209 citations

, , +16

1–5 of 35